Great two presentation today. I did notice the com
Post# of 1418
$1.98B valuation by a well respected 3rd party.
60% of $1.98B = $1.19B which is what Todos owns.
Do some funding and Todos might be left with $1B.
To me, that is pretty, pretty, pretty good for a company with a market cap likely less than their 2022 projected revenue
Oh and none of this includes the breast cancer test coming next year which will be worth a small fortune.